longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Sophia Genetics SA

SOPH

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -8.45, below the reasonable range, cheaper than 90.04% of the time in the past 1 years, and the industry ranks 30/39, the industry Median -0.76.

-8.45xP/E
$8.03Stock price
$-0.95Earnings per share
-8.45xP/E
Stock price$8.03Earnings per share$-0.95

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-4.49x
Typical range
-5.98x–-4.17x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
HTFLUSHeartFlow
-35.93x76.19%$4.25B
SDGRUSSchrodinger
-41.94x13.66%$2.28B
CERTUSCertara
-20.83x1,962.60%$1.42B
TDOCUSTeladoc
-5.81x22.88%$1.03B
MDRXUSVeradigm
----$851.43M
SOPHUSSophia Genetics SA
-8.45x19.83%$683.58M
EVHUSEvolent Health
-0.75x84.41%$383.27M
CTEVUSClaritev
-1.28x12.62%$361.15M
AMWLUSAmerican Well
-2.79x57.74%$218.05M
LFMDUSLifeMD
-47.28x195.82%$137.37M
DHUSDefinitive Healthcare
-0.81x28.60%$135.58M
HCATUSHealth Catalyst
-0.48x4.22%$127.94M
DRIOUSDarioHealth
-8.62x62.43%$60.33M
RNLXYUSRENALYTIX PLC SPON ADS EACH REP 50 ORD (POST SPLIT)
-2.43x--$48.31M
ITOCUSiTonic
-3.75x--$33.45M
ONMDUSOneMedNet
-3.87x--$32.61M
AIFFUSFirefly Neuroscience
-2.43x--$22.91M
BFRGUSBullfrog AI
-1.94x41.27%$11.65M
HCTIUSHealthcare Triangle
-0.62x93.28%$10.51M
SCNXUSScienture
-0.19x91.48%$7.27M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.